Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dendreon Corp.

www.dendreon.com

Latest From Dendreon Corp.

Medicare's CAR-T Panel Underscores Hurdles For PROs – And FDA/CMS Collaboration

MEDCAC meeting demonstrates complexity of patient-reported outcomes and place for PROs in regulatory decision-making compared to coverage.
Medicare Clinical Trials

Remember When Provenge's Price Was Bold? Every New Cancer Drug In 2017 Cost $100,000 Or More

The price of new oncology brands doubled in the US from 2013 to 2017, bringing the median annual price to more than $160,000 last year, up from $79,000 in 2013, according to a new IQVIA report. Spending on cancer drugs in the US has doubled since 2012, reaching nearly $50bn in 2017.

Pricing Debate Pricing Strategies

CAR-T Therapy In Medicare: National Coverage Policy Could Come In 2019

Medicare begins analysis process for CAR-T cancer therapies in response to a request from UnitedHealthcare for a national coverage policy.
Medicare Cancer

CAR-T Drugs Break Ground For Stem Cell Therapies In CNS, Says Brainstorm CEO

Brainstorm’s president and CEO Chaim Lebovits talks to Scrip about the company’s progress with personalized stem cell therapy NurOwn in ALS and what the future holds for cell therapy options in neurology.

See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Activated Cell Therapy
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Dendreon Corp.
  • Senior Management
  • James Caggiano, CEO
    Chris Carr, CFO
    Andrew S Sandler, MD, EVP, CMO
    Matt Kemp, Chief Commercial Officer
  • Contact Info
  • Dendreon Corp.
    Phone: (877) 256-4545
    1208 Eastlake Ave. E
    Seattle, WA 98102
    USA
UsernamePublicRestriction

Register